Together, these trials included 3,377 adults who were treated with either 2 } Thousands of participants were monitored for side effects, and among these participants: 3% of semaglutide users reported hair loss 1% of placebo users reported hair loss At first glance, this difference might suggest that semaglutide does increase the risk of hair loss
Semaglutide targets the GLP-1 hormone, while tirzepatide targets both GLP-1 and GIP
The medication can significantly affect blood sugar, so insulin or other diabetes medications often need reduction to prevent low blood sugar
For people with insurance, the cost depends on the specific plan
Technically, they're GLP-1 receptor agonists, because they work on the same cell receptors as GLP-1 to activate the same response slowing digestion, prompting insulin release, and limiting appetite
Take our short quiz